434 related articles for article (PubMed ID: 28635336)
1. New advances in focal therapy for early stage prostate cancer.
Tay KJ; Schulman AA; Sze C; Tsivian E; Polascik TJ
Expert Rev Anticancer Ther; 2017 Aug; 17(8):737-743. PubMed ID: 28635336
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer: state of the art imaging and focal treatment.
Woodrum DA; Kawashima A; Gorny KR; Mynderse LA
Clin Radiol; 2017 Aug; 72(8):665-679. PubMed ID: 28385253
[TBL] [Abstract][Full Text] [Related]
3. MR-guided biopsy and focal therapy: new options for prostate cancer management.
Elkhoury FF; Simopoulos DN; Marks LS
Curr Opin Urol; 2018 Mar; 28(2):93-101. PubMed ID: 29232269
[TBL] [Abstract][Full Text] [Related]
4. Focal Ablation of Early-Stage Prostate Cancer: Candidate Selection, Treatment Guidance, and Assessment of Outcome.
Edison E; Tariq Shah T; Ahmed HU
Urol Clin North Am; 2017 Nov; 44(4):575-585. PubMed ID: 29107274
[TBL] [Abstract][Full Text] [Related]
5. Integration of PSMA-targeted PET imaging into the armamentarium for detecting clinically significant prostate cancer.
Meyer AR; Joice GA; Allaf ME; Rowe SP; Gorin MA
Curr Opin Urol; 2018 Nov; 28(6):493-498. PubMed ID: 30188333
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging-transrectal ultrasound fusion focal cryotherapy of the prostate: A prospective development study.
Valerio M; Shah TT; Shah P; Mccartan N; Emberton M; Arya M; Ahmed HU
Urol Oncol; 2017 Apr; 35(4):150.e1-150.e7. PubMed ID: 27955940
[TBL] [Abstract][Full Text] [Related]
7. Spatial Tracking of Targeted Prostate Biopsy Locations: Moving Towards Effective Focal Partial Prostate Gland Ablation with Improved Treatment Planning.
Sidelsky S; Setia S; Vourganti S
Curr Urol Rep; 2017 Oct; 18(12):93. PubMed ID: 29046984
[TBL] [Abstract][Full Text] [Related]
8. Targeted prostate biopsy and MR-guided therapy for prostate cancer.
Woodrum DA; Kawashima A; Gorny KR; Mynderse LA
Abdom Radiol (NY); 2016 May; 41(5):877-88. PubMed ID: 26907717
[TBL] [Abstract][Full Text] [Related]
9. How to select the right patients for focal therapy of prostate cancer?
Passoni NM; Polascik TJ
Curr Opin Urol; 2014 May; 24(3):203-8. PubMed ID: 24625428
[TBL] [Abstract][Full Text] [Related]
10. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol.
van den Bos W; de Bruin DM; Muller BG; Varkarakis IM; Karagiannis AA; Zondervan PJ; Laguna Pes MP; Veelo DP; Savci Heijink CD; Engelbrecht MRW; Wijkstra H; de Reijke TM; de la Rosette JJMCH
BMJ Open; 2014 Oct; 4(10):e006382. PubMed ID: 25354827
[TBL] [Abstract][Full Text] [Related]
11. Role of multiparametric magnetic resonance imaging (MRI) in focal therapy for prostate cancer: a Delphi consensus project.
Muller BG; van den Bos W; Brausi M; Cornud F; Gontero P; Kirkham A; Pinto PA; Polascik TJ; Rastinehad AR; de Reijke TM; de la Rosette JJ; Ukimura O; Villers A; Walz J; Wijkstra H; Marberger M
BJU Int; 2014 Nov; 114(5):698-707. PubMed ID: 24180365
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of tumor coverage after MR-guided prostate focal laser ablation therapy.
Knull E; Oto A; Eggener S; Tessier D; Guneyli S; Chatterjee A; Fenster A
Med Phys; 2019 Feb; 46(2):800-810. PubMed ID: 30447155
[TBL] [Abstract][Full Text] [Related]
13. New treatments for localized prostate cancer.
Marberger M; Carroll PR; Zelefsky MJ; Coleman JA; Hricak H; Scardino PT; Abenhaim LL
Urology; 2008 Dec; 72(6 Suppl):S36-43. PubMed ID: 19095127
[TBL] [Abstract][Full Text] [Related]
14. The utility of intraoperative contrast-enhanced ultrasound in detecting residual disease after focal HIFU for localized prostate cancer.
Bacchetta F; Martins M; Regusci S; Jichlinski P; Meuwly JY; Lucca I; Valerio M
Urol Oncol; 2020 Nov; 38(11):846.e1-846.e7. PubMed ID: 32532530
[TBL] [Abstract][Full Text] [Related]
15. New technologies and techniques for prostate cancer focal therapy.
Linares-Espinós E; Carneiro A; Martínez-Salamanca JI; Bianco F; Castro-Alfaro A; Cathelineau X; Valerio M; Sanchez-Salas R
Minerva Urol Nefrol; 2018 Jun; 70(3):252-263. PubMed ID: 29664243
[TBL] [Abstract][Full Text] [Related]
16. Comparison of
Zamboglou C; Drendel V; Jilg CA; Rischke HC; Beck TI; Schultze-Seemann W; Krauss T; Mix M; Schiller F; Wetterauer U; Werner M; Langer M; Bock M; Meyer PT; Grosu AL
Theranostics; 2017; 7(1):228-237. PubMed ID: 28042330
[TBL] [Abstract][Full Text] [Related]
17. Focal therapy for localized prostate cancer in the era of routine multi-parametric MRI.
Connor MJ; Gorin MA; Ahmed HU; Nigam R
Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):232-243. PubMed ID: 32051551
[TBL] [Abstract][Full Text] [Related]
18. Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial.
Scheltema MJ; van den Bos W; de Bruin DM; Wijkstra H; Laguna MP; de Reijke TM; de la Rosette JJ
BMC Cancer; 2016 May; 16():299. PubMed ID: 27150293
[TBL] [Abstract][Full Text] [Related]
19. Surveillance after prostate focal therapy.
Tay KJ; Amin MB; Ghai S; Jimenez RE; Kench JG; Klotz L; Montironi R; Muto S; Rastinehad AR; Turkbey B; Villers A; Polascik TJ
World J Urol; 2019 Mar; 37(3):397-407. PubMed ID: 29948045
[TBL] [Abstract][Full Text] [Related]
20. Evolution of Focal Therapy in Prostate Cancer: Past, Present, and Future.
Arcot R; Polascik TJ
Urol Clin North Am; 2022 Feb; 49(1):129-152. PubMed ID: 34776047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]